Randomised phase III study of intravenous vinorelbine plus hormone therapy versus hormone therapy alone in hormone-refractory prostate cancer
Journal article published in 2004 by
R. P. Abratt,
D. Brune,
M.-A. Dimopoulos,
J. Kliment,
J. Breza,
F. P. Selvaggi,
P. Beuzeboc,
T. Demkow 
,
S. Oudard
,
S. Oudard
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 